Literature DB >> 15071283

Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates.

Qibo Zhang1, Konstantinos Arnaoutakis, Craig Murdoch, Raman Lakshman, Gillian Race, Roger Burkinshaw, Adam Finn.   

Abstract

BACKGROUND: Immunization with conjugate pneumococcal vaccines induces significant primary and memory IgG anti-polysaccharide (PS) responses in serum. It can also induce mucosal responses in infants especially after a polysaccharide booster. However, it is unclear whether it can prime for mucosal memory responses on nasal exposure to pneumococcus, which may be important in protection against pneumococcal invasion and/or carriage.
METHOD: IgA and IgG to serotypes 4, 6B, 9V, 14, 18C, 19F and 23F (conjugate vaccine serotypes), 1 and 3 (nonvaccine serotypes) capsular PS were measured by immunoassay in saliva from 2- to 5-year-old children previously given three doses of 7-valent pneumococcal conjugate vaccine in infancy, followed by 23-valent PS vaccine at 13 months and from unvaccinated controls of similar age and sex. Salivary antibody responses were analyzed in relation to carriage of pneumococci assessed by bacterial culture of nasopharyngeal swab samples collected in the summer and winter of the year 2000.
RESULTS: Rates of detectable IgG antibodies to all vaccine serotypes except 23F were higher in subjects than in controls. No such differences were observed for IgA antibodies except for serotype 6B. Nasal colonization rates were similar, and in both groups mucosal IgA responses were more common and larger than IgG responses.
CONCLUSIONS: The mucosal anti-capsular IgA responses observed could develop in response to colonization in preschool children, regardless of vaccination status, and contribute to the falling carriage rates observed with increasing age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071283     DOI: 10.1097/00006454-200404000-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

Review 1.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

2.  Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children.

Authors:  Qibo Zhang; Jolanta Bernatoniene; Linda Bagrade; James C Paton; Timothy J Mitchell; Sven Hammerschmidt; Desmond A Nunez; Adam Finn
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model.

Authors:  Annemarie M C van Rossum; Elena S Lysenko; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization.

Authors:  Tera L McCool; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Nasopharyngeal carriage of Streptococcus pneumoniae among children in an urban setting in Brazil prior to PCV10 introduction.

Authors:  Ana Paula de O Menezes; Jailton Azevedo; Mariela C Leite; Leila C Campos; Marcelo Cunha; Maria da Gloria S Carvalho; Mitermayer G Reis; Albert I Ko; Daniel M Weinberger; Guilherme Ribeiro; Joice N Reis
Journal:  Vaccine       Date:  2015-12-29       Impact factor: 3.641

6.  Migration of tumor antigen-pulsed dendritic cells after mucosal administration in the human upper respiratory tract.

Authors:  Shigetoshi Horiguchi; Tomokazu Matsuoka; Yoshitaka Okamoto; Daijyu Sakurai; Kouichi Kobayashi; Hideaki Chazono; Toyoyuki Hanazawa; Yuriko Tanaka
Journal:  J Clin Immunol       Date:  2007-06-28       Impact factor: 8.317

7.  The clinical relevance of IgM and IgA anti-pneumococcal polysaccharide ELISA assays in patients with suspected antibody deficiency.

Authors:  Lisanne M A Janssen; Michiel Heron; Jean-Luc Murk; Alexander C A P Leenders; Ger T Rijkers; Esther de Vries
Journal:  Clin Exp Immunol       Date:  2021-06-01       Impact factor: 4.330

8.  Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Authors:  Anu Nurkka; Mika Lahdenkari; Arto A I Palmu; Helena Käyhty
Journal:  BMC Infect Dis       Date:  2005-05-27       Impact factor: 3.090

9.  Interleukin-17A mediates acquired immunity to pneumococcal colonization.

Authors:  Ying-Jie Lu; Jane Gross; Debby Bogaert; Adam Finn; Linda Bagrade; Qibo Zhang; Jay K Kolls; Amit Srivastava; Anna Lundgren; Sophie Forte; Claudette M Thompson; Kathleen F Harney; Porter W Anderson; Marc Lipsitch; Richard Malley
Journal:  PLoS Pathog       Date:  2008-09-19       Impact factor: 6.823

10.  Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life.

Authors:  Gerwin D Rodenburg; Elisabeth A M Sanders; Elske J M van Gils; Reinier H Veenhoven; Tomasz Zborowski; Germie P J M van den Dobbelsteen; Andries C Bloem; Guy A M Berbers; Debby Bogaert
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.